Lumos Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Net Income	110.7	154.7	87.1	180.4	171.01
Depreciation & Amortization	66	65.3	69.6	59.5	44.95
Loss (Gain) From Sale of Assets	-0.7	1	-3.3	-15.1	0.38
Asset Writedown & Restructuring Costs	7.4	1.4	2.1	3.1	-
Loss (Gain) on Equity Investments	8.4	-20.4	4.8	-27.3	-13.47
Stock-Based Compensation	11	10.3	10.4	8.7	10.14
Provision & Write-off of Bad Debts	1.8	1.1	1.6	0.7	-0.18
Other Operating Activities	5.5	16.5	2.9	33.5	12.47
Change in Accounts Receivable	34.1	-1.4	113	-109.7	-220.59
Change in Inventory	-16.7	16.4	154.5	-50.7	-178.38
Change in Accounts Payable	15.8	-26.7	-124.3	-14.9	293.08
Change in Other Net Operating Assets	-13	-18.7	-3.4	-28.7	33.13
Operating Cash Flow	230.3	199.5	315	39.5	152.55
Operating Cash Flow Growth	15.44%	-36.67%	697.47%	-74.11%	-
Capital Expenditures	-130.4	-103.4	-45.5	-36.4	-28.8
Sale of Property, Plant & Equipment	1.3	1.2	23.3	24.6	0.19
Cash Acquisitions	-	-21	-	-383.5	0.93
Investing Cash Flow	-129.1	-123.2	-22.2	-395.3	-27.69
Short-Term Debt Issued	523.7	393.3	-	41.7	-
Long-Term Debt Issued	2.3	-	-	50	-
Total Debt Issued	526	393.3	-	91.7	-
Short-Term Debt Repaid	-522.5	-248.1	-45.2	-	-
Long-Term Debt Repaid	-	-	-15	-15	-
Total Debt Repaid	-522.5	-248.1	-60.2	-15	-
Net Debt Issued (Repaid)	3.5	145.2	-60.2	76.7	-
Issuance of Common Stock	-	0.3	-	-	-
Repurchase of Common Stock	-3.1	-	-	-	-
Common Dividends Paid	-31.9	-7.9	-	-	-
Other Financing Activities	-17	-206.4	-220	281.7	-116.68
Financing Cash Flow	-48.5	-68.8	-280.2	358.4	-116.68
Net Cash Flow	52.7	7.5	12.6	2.6	8.18
Free Cash Flow	99.9	96.1	269.5	3.1	123.75
Free Cash Flow Growth	3.95%	-64.34%	8593.55%	-97.50%	-
Free Cash Flow Margin	3.23%	2.80%	7.47%	0.08%	5.82%
Free Cash Flow Per Share	1.98	1.93	5.47	0.06	-
Cash Interest Paid	-	4.5	-	-	-
Cash Income Tax Paid	-	37.6	-	-	-
Levered Free Cash Flow	3.19	102.78	276.68	-73.83	-
Unlevered Free Cash Flow	7.63	106.53	278.55	-71.95	-
Change in Net Working Capital	37.1	0.3	-159.24	238.25	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.